Reference Committee for the health technology assessment policy and methods review

27 October 2022 - On 6 September 2021, the Commonwealth entered into a new Strategic Agreement in relation to reimbursement, ...

Read more →

FDA accepts Integral Molecular's letter of intent on membrane proteome array antibody specificity test into ISTAND drug development tools pilot program

7 September 2022 - Integral Molecular has been accepted into the US FDA's ISTAND pilot program.  ...

Read more →

CADTH launches post-market drug evaluation program

1 September 2022 - CADTH is pleased to announce the launch of its new post-market drug evaluation program. ...

Read more →

Global expert panel publishes guidance on deliberative processes for health technology assessment

7 June 2022 - Value in Health announced today the publication of guidance regarding the establishment or improvement of deliberative ...

Read more →

Health Technology Assessment Review Reference Committee will drive reform to support Australian patients

10 April 2022 - The Health Technology Assessment Review Reference Committee announced (via the Department of Health website) is tasked ...

Read more →

CADTH launches consultations on proposals to enhance drug review processes

4 April 2022 - CADTH has launched consultations on a proposed process for non-sponsored reimbursement reviews and a streamlined process ...

Read more →

Updates to the procedure guidance for listing medicines on the PBS

15 October 2021 - The Department has updated Section 5.8 New brand of existing pharmaceutical item submissions (not requiring PBAC consideration) ...

Read more →

EU-HTA regulation: methodical preparations for implementation start with IQWiG and G-BA

21 September 2021 - The institute and the G-BA are part of a consortium that is developing the methodological basis ...

Read more →

NICE’s health technology assessment methods and processes to be evaluated

19 August 2021 - NICE has launched a public consultation on proposed changes to the way it develops recommendations across ...

Read more →

Updated financial estimates workbook

6 August 2021 - An updated version of the Utilisation and Cost Model workbook is now available to support PBAC submissions. ...

Read more →

Pilot of new health technology evaluation process for antimicrobials

7 May 2021 - Research to develop novel antibiotics has in recent years been seen as commercially unattractive due to limited ...

Read more →

NICE methods and process review aims to create fertile ground for innovation

29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...

Read more →

Stage 2 PBS process improvements – resubmission pathways webinar

10 March 2021 - Stage 2 PBS process improvements commenced on 1 January 2021. The Department of Health will continue ...

Read more →

NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st

4 January 2020 - Companies can now submit medicines for the new Innovative Licensing and Access Pathway following close collaboration between ...

Read more →

Jacinda Ardern defends Labour's 'perfectly reasonable' decision to veto MP led PHARMAC inquiry

7 December 2020 - Prime Minister Jacinda Ardern is defending Labour's "perfectly reasonable" decision to veto a PHARMAC inquiry led ...

Read more →